To include your compound in the COVID-19 Resource Center, submit it here.

Savient falls on first quarter results

Savient Pharmaceuticals Inc. (NASDAQ:SVNT) fell $2.51 (23%) to $8.57 on Thursday after reporting

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE